Loading...
Market
What will be the outcome of the House of Representatives vote on the Biosecure Act by September 15, 2024?
2
Jim McGovern•Massachusetts•House Rules Committee•Biosecure Act•Chinese•WuXi Biologics•BGI•McGovern•China•American•Chinese Communist Party•House of Representatives
Resolution / Starting Odds
Passes • 33%
Fails • 33%
Postponed • 34%
Official voting records from the House of Representatives
Story
Rep. Jim McGovern Opposes Biosecure Act on National Security Grounds, Targeting WuXi Biologics and BGI
Sep 9, 2024, 07:02 PM
Rep. Jim McGovern of Massachusetts, the ranking member on the House Rules Committee, has announced his opposition to the Biosecure Act on national security grounds. This legislation aims to restrict business with Chinese biotech firms, including WuXi Biologics and BGI, on national security grounds. McGovern's stance has stirred controversy, given his history as a China human-rights advocate. The bill is part of a broader legislative push by U.S. lawmakers to counter China's influence, with other measures targeting Chinese military-linked companies and addressing issues such as data theft and economic competition. The Biosecure Act is seen as critical for protecting American genetic data from the Chinese Communist Party's ambitions in biotechnology. The House of Representatives is expected to vote on the bill this week.
View original story
Similar markets
Passed with amendments • 25%
Passed without amendments • 25%
Rejected • 25%
Postponed • 25%
Passed • 33%
Failed • 33%
Not Voted • 33%
Passes with majority GOP support • 25%
Passes with bipartisan support • 25%
Fails due to lack of support • 25%
Fails due to procedural issues • 25%
Pass • 25%
Fail • 25%
Postponed • 25%
Other • 25%
Passes with majority • 33%
Fails to pass • 33%
Withdrawn before vote • 34%
Passes with majority Republican support • 25%
Passes with bipartisan support • 25%
Fails with majority Democrat opposition • 25%
Fails with bipartisan opposition • 25%
Passed with majority Republican support • 25%
Passed with bipartisan support • 25%
Failed with majority Democrat opposition • 25%
Failed with bipartisan opposition • 25%
Passes with majority support • 25%
Fails with majority opposition • 25%
Postponed for later vote • 25%
Withdrawn from consideration • 25%
Passes with majority • 33%
Fails to pass • 33%
Delayed without vote • 34%
Passed with majority Republican support • 25%
Passed with majority Democratic support • 25%
Failed with majority Republican opposition • 25%
Failed with majority Democratic opposition • 25%